Literature DB >> 3406665

Rubella immunity and morbidity: effects of vaccination in Finland.

P Ukkonen1, C H von Bonsdorff.   

Abstract

The occurrence of rubella antibodies and frequency of virologically proven rubella infections in different age groups were analyzed in a large serum material (about 60,000 sera) collected both before and after the start of nationwide vaccination of children against measles, mumps and rubella in Finland in 1982. The combined live vaccine significantly raised the rubella immunity of children and shifted rubella infections to older ages. In 1986, 91-98% immunity was found in the 2-10-year-old children so far covered by the vaccination programme; no rubella cases were diagnosed in this age group. We also demonstrated that another rubella vaccine given to about 60% of 13-year-old girls since 1975 both raised the immunity and reduced the occurrence of rubella in the vaccinated population. It is concluded that the rubella vaccinations, especially the combined vaccine given to small children, are effective, although the total number of reported rubella cases in the whole population did not decrease significantly during the study period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3406665     DOI: 10.3109/00365548809032448

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

Review 1.  Rubella in Europe.

Authors:  A Galazka
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.

Authors:  H R Babad; D J Nokes; N J Gay; E Miller; P Morgan-Capner; R M Anderson
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

3.  Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.

Authors:  C Pelissero; C Marena; F Aguzzi; M Bevilacqua; F Rebasti
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

Review 4.  Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.

Authors:  Andrea M Anonychuk; Andrea C Tricco; Chris T Bauch; Ba' Pham; Vladimir Gilca; Bernard Duval; Ava John-Baptiste; Gloria Woo; Murray Krahn
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme.

Authors:  L Matter; F Bally; D Germann; K Schopfer
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.